195 related articles for article (PubMed ID: 19000150)
1. Impact of cytokine gene polymorphisms on graft-vs-host disease.
Markey KA; MacDonald KP; Hill GR
Tissue Antigens; 2008 Dec; 72(6):507-16. PubMed ID: 19000150
[TBL] [Abstract][Full Text] [Related]
2. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population.
Laguila Visentainer JE; Lieber SR; Lopes Persoli LB; Dutra Marques SB; Vigorito AC; Penteado Aranha FJ; de Brito Eid KA; Oliveira GB; Martins Miranda EC; Bragotto L; de Souza CA
Cytokine; 2005 Nov; 32(3-4):171-7. PubMed ID: 16243534
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms within the genes encoding TNF-alpha and TNF-beta associate with the incidence of post-transplant complications in recipients of allogeneic hematopoietic stem cell transplants.
Bogunia-Kubik K
Arch Immunol Ther Exp (Warsz); 2004; 52(4):240-9. PubMed ID: 15467488
[TBL] [Abstract][Full Text] [Related]
5. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of cytokine and innate immunity genes and GVHD.
Dickinson AM; Holler E
Best Pract Res Clin Haematol; 2008 Jun; 21(2):149-64. PubMed ID: 18503983
[TBL] [Abstract][Full Text] [Related]
7. Haematopoietic stem cell transplantation: can our genes predict clinical outcome?
Dickinson AM; Harrold JL; Cullup H
Expert Rev Mol Med; 2007 Nov; 9(29):1-19. PubMed ID: 17976248
[TBL] [Abstract][Full Text] [Related]
8. Role of HLA in hematopoietic SCT.
Nowak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
[TBL] [Abstract][Full Text] [Related]
9. Non-HLA genetics and predicting outcome in HSCT.
Dickinson AM
Int J Immunogenet; 2008 Aug; 35(4-5):375-80. PubMed ID: 18976441
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
11. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
[TBL] [Abstract][Full Text] [Related]
12. Total lymphoid irradiation for graft-versus-host disease protection.
Kohrt H; Lowsky R
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S23-6. PubMed ID: 19561409
[TBL] [Abstract][Full Text] [Related]
13. Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation.
MartÃn-Antonio B; Granell M; Urbano-Ispizua A
Expert Rev Hematol; 2010 Aug; 3(4):411-27. PubMed ID: 21083033
[TBL] [Abstract][Full Text] [Related]
14. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.
Bertinetto FE; Dall'Omo AM; Mazzola GA; Rendine S; Berrino M; Bertola L; Magistroni P; Caropreso P; Falda M; Locatelli F; Busca A; Amoroso A
Int J Immunogenet; 2006 Oct; 33(5):375-84. PubMed ID: 16984283
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 gene polymorphism in bone marrow transplant recipients.
Azarpira N; Ramzi M; Aghdaie MH; Darai M; Geramizadeh B
Exp Clin Transplant; 2008 Mar; 6(1):74-9. PubMed ID: 18405249
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms predicting the outcome of bone marrow transplants.
Dickinson AM; Middleton PG; Rocha V; Gluckman E; Holler E;
Br J Haematol; 2004 Dec; 127(5):479-90. PubMed ID: 15566351
[TBL] [Abstract][Full Text] [Related]
17. GVHD pathophysiology: is acute different from chronic?
Toubai T; Sun Y; Reddy P
Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979
[TBL] [Abstract][Full Text] [Related]
18. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
[TBL] [Abstract][Full Text] [Related]
19. Acute GvHD: pathogenesis and classification.
Ball LM; Egeler RM;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S58-64. PubMed ID: 18545246
[TBL] [Abstract][Full Text] [Related]
20. Predicting outcome in hematological stem cell transplantation.
Dickinson AM; Cavet J; Cullup H; Wang XN; Jarvis M; Sviland L; Middleton PG
Arch Immunol Ther Exp (Warsz); 2002; 50(6):371-8. PubMed ID: 12546063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
